Polliesdividend

New buy – Johnson & Johnson

I made a new buy for my Vrijheid Fonds.

Johnson & Johnson (JNJ) is one of the foundation stocks of my Vrijheid Fonds. It is always on my watch list and one of my “always buy” stocks. We all know that JNJ has been one of the most consistent and successful companies on earth. This Dividend King has paid dividends since 1944 and has managed to increase them for 54 years in a row! How can you not love this company?

 

Polliesdividend.com

 

The stock has historically never been truly cheap, and I think it never will be, this because investors recognize and price great companies accordingly.

If we look at the valuation, we can see that the average annual P/E ratio for Johnson & Johnson over the past 15 years has fluctuated from a low of 12.5 in 2009 to a high of 27 back in 2002. In the beginning of this month the P/E has been in the 17 – 18 range. This gave me a great opportunity to buy some extra stocks of this great company.

On the basis of this information/research I took action.

 

Purchase

Two weeks ago I bought 15 shares of JNJ at $116.66 per share (incl. fees). With this buy I added a little bit more than €39 (after taxes) of dividend to my Vrijheid Fonds for this year. My projected annual (2017) total amount from my shares of JNJ will be $116 after taxes

The projected dividend income for 2017 for my Vrijheid Fonds is €3,010.

Again a small step in my journey and one-step closer to my goal. Has anyone invested in this company recently? Any feedback is greatly appreciated!

Cheers,

Pollie

 

DISCLAIMER: I’M NOT A REGISTERED INVESTMENT ADVISER, INVESTMENT PROFESSIONAL, BROKERAGE FIRM OR INVESTMENT COMPANY. READERS ARE ADVISED THAT INFORMATION ON THE WEBSITE IS ISSUED SOLELY FOR INFORMATION PURPOSES AND NOT TO BE CONSTRUED AS AN OFFER OR RECOMMENDATION TO BUY, HOLD, OR SELL ANY SECURITIES. ALL INFORMATION, OPINIONS, AND ANALYSES INCLUDED ARE BASED ON SOURCES BELIEVED TO BE RELIABLE, BUT NO REPRESENTATION OR WARRANTY IS MADE CONCERNING ACCURACY, CORRECTNESS, TIMELINESS, OR APPROPRIATENESS. PLEASE CONSULT WITH AN INVESTMENT PROFESSIONAL BEFORE INVESTING ANY OF YOUR MONEY.

 

Please follow and like us:
0

18 thoughts on “New buy – Johnson & Johnson

  1. DivHut

    A foundation stock indeed. Long term there’s not much to dislike about JNJ. It’s a solid stock that belongs in every long term dividend growth portfolio. Thanks for sharing.

Leave a Reply

Your email address will not be published. Required fields are marked *